Looking at their new items there was a story about them in 2015 with the story that they expected to have a drug in clinical trials in 2016. On the merger webcast they are saying they will not be in humans for another 18 months to 2 years.
If they have been so far off before why should I believe the new estimate.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.